Close Menu

NEW YORK — Fios Genomics will provide bioinformatics, statistics, and computational biology services to Charles River Laboratories International under a partnership announced Thursday. 

Edinburgh, UK-based Fios Genomics will help Charles River, of Wilmington, Massachusetts, with sourcing and analysis of multi-variant datasets to inform drug discovery. These datasets will cover microarrays, next-generation sequencing, proteomics, metabolomics, and epigenetics, plus the associated metadata, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.